![1]()
News
J&J COVID-19 vaccine wins unanimous backing of FDA panel
February 27, 2021
The Johnson & Johnson vaccine is expected to offer more convenient dosing and be easier to distribute than the two rival products already available in the United States.
News
PTSD prevalent in survivors of severe COVID-19
February 26, 2021
The results are “in line” with findings reported in other events, such as Hurricane Katrina of 2005, and the 2011 Japan earthquake and tsunami.
News
Seeking the next generation of antibiotics
February 26, 2021
Researchers are exploring gene-editing technology to address the resistance crisis.
![1]()
News
New-onset arrhythmias low in COVID-19 and flu
February 26, 2021
Overall, incidence of AF/AFL and new onset AF/AFL was similar in COVID-19 vs. influenza. Mortality in those with arrhythmias also increased to a similar extent in both diseases.
![1]()
News
Variant found in NYC, Northeast
February 26, 2021
“A concern is that it might be beginning to overtake other strains, just like the U.K. and South African variants,” said Dr. David Ho.
![1]()
News
Myocardial injury seen on MRI in 54% of recovered COVID-19 patients
February 25, 2021
Two months after discharge, 54% of hospitalized COVID-19 patients with troponin elevation showed signs of myocardial injury on MRI, some of which was likely pre-existing, the authors say.
![1]()
News
Janssen/J&J COVID-19 vaccine cuts transmission, new data show
February 24, 2021
"The decrease in asymptomatic transmission is very welcome news too in curbing the spread of the virus."
![1]()
News
Loss of smell lingers post COVID-19
February 24, 2021
The fact that the sense of smell had not returned to normal for half the participants so long after being infected is “novel and quite striking.”
![1]()
News
New cases of child COVID-19 drop for fifth straight week
February 23, 2021
Weekly cases fall to a level not seen since late October and new deaths drop below double digits.
News
Variants spur new FDA guidance on COVID vaccines, tests, drugs
February 23, 2021
The FDA has already been communicating with individual manufacturers as they assess the variants’ effect on their products.
